168 related articles for article (PubMed ID: 11220886)
21. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function.
Saelen MG; Prøsch LK; Gudmundsdottir H; Dyrbekk D; Helge Hunderi O; Arnesen E; Paulsen D; Skjønsberg H; Os I
Blood Press; 2005; 14(3):170-6. PubMed ID: 16036497
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
23. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
24. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
Remuzzi G; Macia M; Ruggenenti P
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
[TBL] [Abstract][Full Text] [Related]
25. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
Ferrari P
Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
[TBL] [Abstract][Full Text] [Related]
26. Concomitant administration of isradipine and spirapril prevents reduction of renal function induced by acute administration of spirapril in patients with reduced renal function.
Wittenberg C; Erman A; Shohat J; Boner G
Blood Press Suppl; 1994; 1():48-9. PubMed ID: 8205299
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin converting enzyme inhibitor and chronic renal failure.
Sitprija V; Lumlertgul D
J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II antagonists--therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy.
Ribeiro AB
Curr Med Res Opin; 2006 Jan; 22(1):1-16. PubMed ID: 16393425
[TBL] [Abstract][Full Text] [Related]
29. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
Kamper AL; Strandgaard S; Leyssac PP
Ugeskr Laeger; 1993 Aug; 155(31):2406-9. PubMed ID: 8346593
[TBL] [Abstract][Full Text] [Related]
30. The HOPE Study (Heart Outcomes Prevention Evaluation).
Sleight P
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
[TBL] [Abstract][Full Text] [Related]
31. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
Steele JL; Henik RA; Stepien RL
Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
33. The effects of enalapril on blood pressure, renal hemodynamics, and renal function.
Weir MR
Clin Ther; 1989; 11(5):685-700. PubMed ID: 2553260
[TBL] [Abstract][Full Text] [Related]
34. [Diabetic nephropathy and arterial hypertension: the physiopathological aspects and antihypertensive treatment].
Savazzi GM; Castiglioni A
Ann Ital Med Int; 1992; 7(3):160-4. PubMed ID: 1457255
[TBL] [Abstract][Full Text] [Related]
35. [Therapy of diabetic nephropathy. Effects of ACE inhibition on microcirculation].
Haak T; Haak E; Jungmann E; Kusterer K; Usadel KH
Fortschr Med; 1997 Dec; 115(35-36):26-9. PubMed ID: 9499637
[TBL] [Abstract][Full Text] [Related]
36. [ACE inhibitors and kidney].
Ritz E
Wien Med Wochenschr; 1990 Jan; 140(1-2):18-21. PubMed ID: 2408246
[TBL] [Abstract][Full Text] [Related]
37. ACE inhibition and renal protection.
Ritz E
Clin Physiol Biochem; 1992; 9(3):94-7. PubMed ID: 1302163
[TBL] [Abstract][Full Text] [Related]
38. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
Nørgaard K; Jensen T; Christensen P; Feldt-Rasmussen B
Blood Press; 1993 Dec; 2(4):301-8. PubMed ID: 8173700
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
Tolins JP; Raij L
Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]